Inovio Pharmaceuticals Lands $6.9 Million Grant to Fund a Clinical Trial for Its Coronavirus VaccineThe Motley Fool • 04/16/20
Inovio Pharmaceuticals Kicks Off Phase 1 Clinical Trial for Experimental COVID-19 VaccineThe Motley Fool • 04/06/20
Inovio Pharmaceuticals plans first dosing of patients in trial of DNA COVID-19 vaccine candiate on MondayMarket Watch • 04/06/20